Home      |      About us      |      Products      |      R&D      |      Order      |      Contact us http://www.chirofinechem.com
  Fluorocompounds
  4-Aminobenzotrifluoride
2-Aminobenzotrifluoride
3-Fluoro Phenol
3-Fluoro Anisole
2-Fluoro-4-Bromo toluene
  Photochemicals
  5,5-Dimethyl-2,4-oxazolidinedione
Methyl 4,4-Dimethyl-3-Oxovalerate
  Azo-series
  2,2'-Azodiisobutyronitrile
2,2'-Azobis(2,4-dimethyl valeronitrile)
  Electronical high purity reagent
  Perchloric acid
  Animal Drugs, Pesticide
  Antiparasitic drugs
  Antibacterial drugs
  Pesticide
  Antiseptic
  Herbicide
 

HANGZHOU CHIROFINE CHEMICALS CO.,LTD. is a technology based company Located in Hangzhou , China . It specialized in researching and developing and synthesis of fine chemicals. We offer custom manufacturing of advanced organic intermediates to major industrial companies around the world. Based on our R&D centre in USA , we have three co-operated production sites and one joint venture. Hangzhou Chirofine is organized to be flexible and responsive to customer needs to create more value for its customers. This includes a rapid response policy to customer inquiries, direct and open customer dialogue and the ability for quick and reliable increase of production from grams to multi-tons. We continuously improve the quality and efficiency of the production process.

We mainly focused on electronic chemicals, photo chemicals, fluoro compounds, azo-series and also intermediates for agrochemicals and pharmaceuticals.

We established biz relationship with several multi-national co. and get their approval on management of productions and quality controls.

To meet our customer's needs is always our pursue. We are expecting collaborations with you.

  Address:
RM1208,Chuangye Building,199
Wensan RD. Hangzhou,China
 
Post/ZIP:310012
Tel:+86-571-88219569
      +86-571-88212513
Fax:+86-571-88925203
E-mail:
hzcfc@chirofinechem.com
 
 
Copyright(C)2007,HANGZHOU CHIROFINE CHEMICALS CO.,LTD. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice